Faculty - YONEZAWA Takayuki |

（Last updated : 2024-03-12 17:17:00）

YONEZAWA Takayuki

Department / Course Graduate School of Bioscience and Biotechnology Gary Young Science Foundation Research Institute

Job Associate Professor

Academic background
2012/01 Degree Acquisition	Tohoku University
2000/04～2002/03	Doctoral Program (1st Semester) Department of Disability Science Graduate School of Medicine Tohoku University Finished
1994/04～1999/03	Department of Pharmacy Faculty of Pharmaceutical Sciences Tohoku University Graduated

Business career
2020/10 ～	Former Institution / Organization Chubu University Research Institute for Biological Functions
2012/04 ～ 2015/03	The University of Tokyo The Graduate School of Engineering Department of Bioengineering
2008/04 ～ 2012/03	The University of Tokyo Graduate School of Medicine
2007/06 ～ 2008/03	The University of Tokyo Graduate School of Medicine
2002/04 ～ 2002/09	Tohoku University

Belonging society
	The Pharmaceutical Society of Japan
	Japan Society for Bioscience, Biotechnology, and Agrochemistry
	Japan Society of Nutrition and Food Science
	Japanese Association for Animal Cell Technology
	Japanese Society for Medical Use of Functional Foods
Display All（6）

Present specialized field
Environmental and natural pharmaceutical resources, Food sciences, Dermatology, Bioorganic chemistry

Book and thesis
Papers	Prenylflavonoids from fruit of Macaranga tanarius promote glucose uptake via AMPK activation in L6 myotubes. Journal of natural medicines 75 (4),pp.813-823 2021/09
Papers	Effects of Baccharin Isolated from Brazilian Green Propolis on Adipocyte Differentiation and Hyperglycemia in ob/ob Diabetic Mice. International journal of molecular sciences 22 (13) 2021/06/28
Papers	Effect of methoxyflavones contained in Kaempferia parviflora on CRE-mediated transcription in PC12D cells. Bioorganic & medicinal chemistry letters 30 (23),pp.127606-127606 2020/12/01
Papers	Molecular mechanism for nobiletin to enhance ABCA1/G1 expression in mouse macrophages. Atherosclerosis 297,pp.32-39 2020/02/06
Papers	A chalcone derivative suppresses the induction of TSLP in mice and human keratinocytes and attenuates OVA-induced antibody production in mice. European journal of pharmacology 851,pp.52-62 2019/05
Display All（67）

Acquisition patent
2010/09/28	Composition for preventing and/or treating bone disease, physiologically functional or health food containing thereof, and pharmaceutical containing thereof as active ingredients （米国特許第7,803,844号）